BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20653354)

  • 1. Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.
    Kreutz RP; Stanek EJ; Aubert R; Yao J; Breall JA; Desta Z; Skaar TC; Teagarden JR; Frueh FW; Epstein RS; Flockhart DA
    Pharmacotherapy; 2010 Aug; 30(8):787-96. PubMed ID: 20653354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators.
    Harjai KJ; Shenoy C; Orshaw P; Usmani S; Boura J; Mehta RH
    Circ Cardiovasc Interv; 2011 Apr; 4(2):162-70. PubMed ID: 21386091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
    Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
    Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major adverse cardiac events among postpercutaneous coronary intervention patients on clopidogrel and proton pump inhibitors.
    Ching GG; Li D; Baker WL; Hohl PK; Mather JF; McKay RG; Lundbye JB
    Conn Med; 2012 Apr; 76(4):205-11. PubMed ID: 22611719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
    Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
    J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
    Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
    Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
    Sarafoff N; Sibbing D; Sonntag U; Ellert J; Schulz S; Byrne RA; Mehilli J; Schömig A; Kastrati A
    Thromb Haemost; 2010 Sep; 104(3):626-32. PubMed ID: 20664905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
    Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S
    Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study.
    van Boxel OS; van Oijen MG; Hagenaars MP; Smout AJ; Siersema PD
    Am J Gastroenterol; 2010 Nov; 105(11):2430-6; quiz 2437. PubMed ID: 20736935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Zuern CS; Geisler T; Lutilsky N; Winter S; Schwab M; Gawaz M
    Thromb Res; 2010 Feb; 125(2):e51-4. PubMed ID: 19781742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Interaction between clopidogrel and proton pump inhibitors.
    Howard PA; Vacek JL
    Am J Cardiovasc Drugs; 2009; 9(6):353-9. PubMed ID: 19929033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation.
    Rossini R; Capodanno D; Musumeci G; Lettieri C; Lortkipanidze N; Romano M; Nijaradze T; Tarantini G; Cicorella N; Sirbu V; Guagliumi G; Rosiello R; Valsecchi O; Gavazzi A
    Coron Artery Dis; 2011 May; 22(3):199-205. PubMed ID: 21358542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.
    Collet JP; Montalescot G; Steg PG; Steinhubl SR; Fox KA; Hu TF; Johnston SC; Hamm CW; Bhatt DL; Topol EJ
    Arch Cardiovasc Dis; 2009; 102(6-7):485-96. PubMed ID: 19664568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of early outcomes after primary stenting in Japanese patients with acute myocardial infarction between clopidogrel and ticlopidine in concomitant use with proton-pump inhibitor.
    Tanaka A; Sakakibara M; Okumura S; Okada K; Ishii H; Murohara T
    J Cardiol; 2012 Jul; 60(1):7-11. PubMed ID: 22445597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
    Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D
    Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.
    Huang CC; Chen YC; Leu HB; Chen TJ; Lin SJ; Chan WL; Chen JW
    Am J Cardiol; 2010 Jun; 105(12):1705-9. PubMed ID: 20538118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.
    Kwok CS; Loke YK
    Aliment Pharmacol Ther; 2010 Apr; 31(8):810-23. PubMed ID: 20102352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.